Profile data is unavailable for this security.
About the company
Teleflex Incorporated is a global provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The Company has four segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM (Original Equipment Manufacturer and Development Services). OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Its OEM division includes the TFX Medical OEM, TFX OEM, Deknatel and HPC Medical brands, provides custom extrusions, micro-diameter film-cast tubing, diagnostic and interventional catheters, balloons and balloon catheters, film-insulated fine wire, coated mandrel wire, conductors, sheath/dilator introducers, and others. Its other brands include Arrow, LMA, Pilling, QuikClot, Rusch, UroLift, Weck and Barrigel.
- Revenue in USD (TTM)3.00bn
- Net income in USD296.02m
- Incorporated1943
- Employees14.50k
- LocationTeleflex Inc550 E Swedesford Rd, Suite 400WAYNE 19087United StatesUSA
- Phone+1 (610) 225-6800
- Fax+1 (610) 948-5101
- Websitehttps://www.teleflex.com/
More ▼
Mergers & acquisitions
| Acquired company | TFX:NYQ since announced | Transaction value |
|---|---|---|
| Palette Life Sciences AB | -13.39% | 650.00m |
Data delayed at least 15 minutes, as of Jul 19 2024 21:10 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Masimo Corp | 1.98bn | 79.10m | 5.80bn | 3.80k | 74.43 | 4.24 | 33.02 | 2.93 | 1.46 | 1.46 | 36.54 | 25.71 | 0.6507 | 2.01 | 5.24 | 519,973.70 | 2.60 | 8.65 | 3.17 | 10.31 | 48.61 | 57.30 | 4.00 | 12.03 | 1.31 | 3.61 | 0.3909 | 0.00 | 0.6042 | 19.00 | -43.21 | -15.96 | 31.06 | -- |
| Glaukos Corp | 326.43m | -140.87m | 6.25bn | 907.00 | -- | 13.73 | -- | 19.16 | -2.88 | -2.88 | 6.68 | 9.04 | 0.3426 | 1.72 | 7.74 | 359,905.20 | -14.78 | -8.73 | -15.91 | -9.35 | 76.18 | 74.77 | -43.16 | -28.69 | 4.68 | -38.38 | 0.4395 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
| Stevanato Group SpA | 1.18bn | 148.92m | 6.54bn | 5.64k | 38.59 | -- | 33.70 | 5.52 | 0.5616 | 0.5616 | 4.46 | -- | -- | -- | -- | 210,269.70 | -- | -- | -- | -- | 30.81 | -- | 12.57 | -- | -- | 32.91 | -- | -- | 10.34 | -- | 1.95 | -- | -- | -- |
| Repligen Corp | 607.45m | 14.84m | 7.39bn | 1.78k | 524.17 | 3.75 | 87.53 | 12.17 | 0.2524 | 0.2524 | 10.74 | 35.29 | 0.2255 | 1.43 | 4.87 | 340,689.80 | 0.551 | 4.38 | 0.6179 | 5.03 | 47.73 | 55.43 | 2.44 | 15.91 | 5.24 | -- | 0.2284 | 0.00 | -20.31 | 26.91 | -77.64 | 20.13 | 24.99 | -- |
| Penumbra Inc | 1.10bn | 93.39m | 7.88bn | 4.20k | 85.50 | 6.54 | 64.79 | 7.19 | 2.38 | 2.38 | 27.90 | 31.05 | 0.7366 | 1.03 | 5.49 | 260,899.80 | 6.28 | 2.32 | 6.98 | 2.61 | 65.04 | 63.90 | 8.52 | 3.17 | 3.51 | -- | 0.0207 | 0.00 | 24.95 | 18.93 | 4,643.16 | 68.60 | 9.64 | -- |
| Lantheus Holdings Inc | 1.37bn | 460.53m | 8.43bn | 834.00 | 18.56 | 8.91 | 16.17 | 6.17 | 6.55 | 6.55 | 19.42 | 13.64 | 0.8587 | 8.78 | 4.71 | 1,637,434.00 | 28.96 | 6.69 | 34.54 | 7.73 | 64.02 | 53.90 | 33.72 | 9.02 | 4.55 | -- | 0.3733 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
| Bio Rad Laboratories Inc | 2.61bn | -322.37m | 8.91bn | 8.03k | -- | 1.00 | -- | 3.42 | -10.36 | -10.36 | 89.91 | 317.32 | 0.1983 | 1.58 | 5.52 | 324,438.10 | -2.45 | 9.08 | -2.56 | 9.60 | 53.53 | 55.55 | -12.37 | 41.97 | 4.89 | 0.4446 | 0.117 | 0.00 | -4.67 | 3.13 | 82.43 | -- | 3.83 | -- |
| Henry Schein, Inc. | 12.45bn | 388.00m | 9.12bn | 25.00k | 24.07 | 2.54 | 13.78 | 0.7325 | 2.96 | 2.96 | 95.11 | 28.02 | 1.33 | 4.74 | 8.00 | 498,040.00 | 4.20 | 6.09 | 6.80 | 10.44 | 31.38 | 30.04 | 3.16 | 4.40 | 1.02 | 8.26 | 0.3207 | 0.00 | -2.44 | 5.55 | -22.68 | -0.1456 | 21.27 | -- |
| Bruker Corp | 3.00bn | 401.60m | 9.70bn | 9.71k | 23.41 | 6.58 | 18.44 | 3.23 | 2.74 | 2.74 | 20.44 | 9.74 | 0.7257 | 1.53 | 5.78 | 309,148.00 | 9.71 | 8.38 | 13.45 | 11.40 | 50.43 | 49.85 | 13.38 | 11.39 | 0.8889 | 156.50 | 0.4872 | 9.81 | 17.14 | 9.36 | 44.03 | 18.91 | 16.79 | 4.56 |
| Globus Medical Inc | 1.90bn | 66.63m | 9.83bn | 5.00k | 115.21 | 2.51 | 39.40 | 5.18 | 0.632 | 0.632 | 15.48 | 29.04 | 0.5353 | 1.26 | 5.01 | 379,690.80 | 1.88 | 6.90 | 2.17 | 7.45 | 62.14 | 71.73 | 3.51 | 14.05 | 1.29 | -- | 0.0977 | 0.00 | 53.34 | 17.08 | -35.39 | -4.72 | 5.57 | -- |
| Teleflex Inc | 3.00bn | 296.02m | 10.85bn | 14.50k | 36.81 | 2.41 | 19.93 | 3.61 | 6.26 | 6.23 | 63.41 | 95.61 | 0.417 | 2.14 | 6.99 | 206,993.50 | 4.11 | 5.86 | 4.47 | 6.42 | 55.70 | 54.43 | 9.86 | 14.62 | 1.41 | 7.67 | 0.2808 | 15.84 | 6.57 | 3.97 | -1.47 | 12.73 | 2.51 | 0.00 |
| Insulet Corp | 1.78bn | 234.00m | 13.84bn | 3.00k | 61.53 | 17.50 | 44.89 | 7.77 | 3.21 | 3.21 | 23.61 | 11.29 | 0.7249 | 1.36 | 6.62 | 593,566.70 | 9.53 | 2.71 | 11.42 | 3.14 | 68.86 | 65.81 | 13.14 | 4.28 | 2.75 | 65.58 | 0.6393 | 0.00 | 30.02 | 24.66 | 4,384.78 | 128.77 | -7.63 | -- |
| Revvity Inc | 2.73bn | 183.35m | 13.99bn | 11.50k | 76.78 | 1.78 | 22.79 | 5.13 | 1.48 | 1.21 | 21.96 | 63.54 | 0.1942 | 2.87 | 4.64 | 237,011.00 | 1.31 | 4.76 | 1.46 | 5.39 | 55.52 | 57.19 | 6.73 | 15.34 | 1.92 | 6.11 | 0.3307 | 6.52 | -16.95 | -0.1982 | -64.99 | -5.28 | -2.69 | 0.00 |
| Avantor Inc | 6.87bn | 260.00m | 14.55bn | 14.50k | 55.99 | 2.73 | 22.02 | 2.12 | 0.3826 | 0.3826 | 10.12 | 7.86 | 0.525 | 5.32 | 5.71 | 473,565.50 | 1.99 | 2.97 | 2.26 | 3.35 | 33.63 | 33.44 | 3.79 | 5.06 | 1.05 | 3.03 | 0.4994 | 0.00 | -7.26 | 3.51 | -51.52 | -- | 31.17 | -- |
Data as of Jul 19 2024. Currency figures normalised to Teleflex Inc's reporting currency: US Dollar USD
63.52%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| T. Rowe Price Investment Management, Inc.as of 31 Mar 2024 | 7.04m | 14.95% |
| Janus Henderson Investors US LLCas of 31 Mar 2024 | 5.40m | 11.47% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 5.35m | 11.36% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 2.65m | 5.64% |
| Atlanta Capital Management Co. LLCas of 31 Mar 2024 | 2.20m | 4.67% |
| Wellington Management Co. LLPas of 31 Mar 2024 | 2.16m | 4.59% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 2.04m | 4.33% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2024 | 1.26m | 2.67% |
| Geode Capital Management LLCas of 31 Mar 2024 | 1.07m | 2.27% |
| Cooke & Bieler LPas of 31 Mar 2024 | 740.46k | 1.57% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
